In this study, we want to see how well a new drug called Quizartinib works for people with Leukemia who do not have a specific mutation called FLT3-ITD. We want to see if this new drug helps improve the condition.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Joshua Zeidner
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Leukemia)
24-1672